PMI acquisition of gums manufacturer ‘shows company strategy on alternatives’

PMI’s acquisition of Fertin Pharma, a Danish manufacturer of gums and other oral products, indicates the company’s strategy to ensure “corporate survival” in the tobacco-alternatives sector, experts believe...
Unlock access

Want the full analysis? Let's talk

We share insights with professionals we’re in contact with. Let us know a bit about your interest.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*

Want the full analysis? Let's talk

We share insights with professionals we’re in contact with. Let us know a bit about your interest.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*